Post-Transfusion Hepatitis C Virus Infection

Steven Kleinman, Michael Busch, Paul Holland, Kenrad E. Nelson, James G. Donahue, Veronica Stambolis

Research output: Contribution to journalLetter

Abstract

To the Editor: The report by Donahue et al. (Aug. 6 issue)1 documented the dramatic decrease in the risk of transmitting hepatitis C virus (HCV) through blood transfusion as a result of sequential improvements in blood-donor testing over the past five years. The authors' data included measurements of the risk of HCV from blood screened by tests for surrogate markers of non-A, non-B hepatitis (antibody to the hepatitis B core antigen [anti-HBc] and elevated levels of alanine aminotransferase) and by a first-generation enzyme immunoassay (EIA) for antibodies to HCV (anti-HCV). The authors stated that the recent implementation of a second-generation…

Original languageEnglish (US)
Pages (from-to)1601-1602
Number of pages2
JournalNew England Journal of Medicine
Volume327
Issue number22
DOIs
StatePublished - Nov 26 1992

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kleinman, S., Busch, M., Holland, P., Nelson, K. E., Donahue, J. G., & Stambolis, V. (1992). Post-Transfusion Hepatitis C Virus Infection. New England Journal of Medicine, 327(22), 1601-1602. https://doi.org/10.1056/NEJM199211263272216